New Edge Advisors, LLC Chroma Dex Corp. Transaction History
New Edge Advisors, LLC
- $16 Billion
- Q4 2024
A detailed history of New Edge Advisors, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, New Edge Advisors, LLC holds 2,173 shares of CDXC stock, worth $12,755. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,173
Previous 13,369
83.75%
Holding current value
$12,755
Previous $48,000
77.08%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CDXC
# of Institutions
122Shares Held
20.3MCall Options Held
149KPut Options Held
26.3K-
Vanguard Group Inc Valley Forge, PA3.39MShares$19.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$18.3 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.59MShares$15.2 Million5.52% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.61 Million0.14% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.78 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $401M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...